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Nutriosomes, new phospholipid nanovesicles specifically designed for intestinal protection were 
developed by simultaneously loading a water-soluble dextrine (Nutriose® FM06) and a natural 
antioxidant (curcumin). Nutriosomes were easily fabricated in a one-step, organic solvent-free 
procedure. The stability and the delivery performances of the vesicles were improved by adding 
hydroxypropylmetylcellulose. All the vesicles were small in size (mean diameter ~168 nm), 
negatively charged (zeta potential ~-38 mV, irrespective of their composition), self-assembled 
predominantly in unilamellar vesicles stabilized by the presence of Nutriose®, which was located in 
both the inter-lamellar and inter-vesicle medium, as confirmed by cryo-TEM and SAXS 
investigation. The dextrin acted also as a cryo-protector, avoiding vesicle collapse during the 
lyophilization process, and as a protector against high ionic strength and pH changes encountered in 
the gastrointestinal environment. Thanks to the antioxidant properties of curcumin, nutriosomes 
provided an optimal protective effect against hydrogen peroxide-induced oxidative stress in Caco-2 
cells. Moreover, these innovative vesicles showed promising efficacy in vivo, as they improved the 
bioavailability and the biodistribution of both curcumin and dextrin upon oral administration, which 
acted synergically in reducing colonic damage chemically-induced in rats. 
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Starchs are abundant, low-cost, renewable and biodegradable molecules frequently used in food, 
papermaking, packaging industries, and textiles as well as in medicine, pharmacy and cosmetics. 
Their indigestible form is often used as a fiber supplement, and they are indispensable constituents 
of healthy diet, since their daily use promotes beneficial physiological effects by lowering 
cholesterol, triglycerides, and glucose levels 1,2. Additionally, exposure to stress, alcohol or drugs 
diminishes the populations of microorganisms that naturally flourish in human intestine, and some 
fibers can exert a prebiotic action by nourishing and replenishing the healthy flora of the digestive 
tract 3. The dietary use of prebiotics can prevent diarrhoea, intestinal irritation, ulcer, and colon 
cancer. Dextrins are low-molecular weight carbohydrates derived from dextrose and obtained from 
the hydrolysis of starch. The indigestible form of dextrin is often used as a fiber supplement. 
Nutriose® is an indigestible dextrin fiber (85%), sugar free, off-taste, water soluble, and stable at 
low pH. It possesses α1-2, α1-3 linkages that cannot be hydrolysed in the small intestine of 
mammals, but are fermented by intestinal bacteria 4. Previous studies demonstrated that a daily dose 
of up to ~90 g of Nutriose® is well tolerated in man and provides beneficial effects on intestinal 
flora 5. Moreover, its use in pharmaceutical formulations can offer protection against colitis, in 
synergy with a natural flavonoid 6. 
Antioxidant flavonoids have been widely used as protective and curative agents in intestinal 
pathologies, and chronic inflammatory colon disorders 7–9. Their loading in nanoparticulate systems 
plays an important role in maximizing their efficacy, thanks to enhanced bioavailability and 
targeted delivery 6,10. 
In the present work, a soluble dextrin (Nutriose® FM06) and a potent natural antioxidant, curcumin, 
were combined with phospholipids to obtain promising oral delivery systems, named nutriosomes. 
The novelty and the advances of this study include the development of nutriosomes by a smart and 
green method: they self-assembled predominantly in unilamellar nanovesicles where the dextrin is 
solubilized in the aqueous compartment within the vesicles, as well as in the inter-vesicle medium, 



































































thus playing a double role of payload and vesicle structuring agent. Moreover, the simultaneous 
nanoincorporation of prebiotic Nutriose® and antioxidant curcumin provide a converging efficacy 
on intestinal health. Nutriosomes were further modified by adding hydroxypropylmetylcellulose, 
which is expected to improve their stability 11. Nutriosomes were deeply characterized, and their in 
vitro and in vivo performances were studied. In particular, the in vitro resistance of vesicles to pH 
and ionic strength was evaluated, along with their internalization by intestinal cells, and their 
protective effect against oxidative stress. Moreover, the chemical stability of curcumin and its 
release from the vesicle formulations were investigated. The in vivo biodistribution of vesicles after 
oral administration and the efficacy against chemically-induced colitis were also evaluated. 
 
2. EXPERIMENTAL SECTION 
Materials 
Soy phosphatidylcholine (Phospholipon® 90G, P90G) was purchased from Lipoid GmbH 
(Ludwigshafen, Germany). Nutriose FM06®, a soluble dextrin from maize, was kindly provided by 
Roquette (Lestrem, France). Curcumin, hydroxypropylmetylcellulose (HPMC), 2,4,6-
trinitrobenzenesulfonic acid (TNBS), and other reagents were purchased from Sigma-Aldrich 
(Milan, Italy). All the products and solvents were of analytical grade. 
Sample preparation 
To prepare nutriosomes, P90G (320 mg), curcumin (20 mg), Nutriose® (100 mg), 
hydroxypropylmetylcellulose (2 mg, when appropriate) were weighed in a glass flask, hydrated 
with 2 ml of bidistilled water and left swelling for 5 h. Then, the suspension was sonicated (2 sec on 
and 2 sec off, 30 cycles; 13 microns of probe amplitude) with a high intensity ultrasonic 
disintegrator (Soniprep 150, MSE Crowley, London, UK). Liposomes without Nutriose® were used 
as a reference. The exact sample composition is reported in Table 1. The samples were purified 
from non-incorporated curcumin by dialysis against water using Spectra/Por® membranes (12-14 
kDa MW cut-off; Spectrum Laboratories Inc., DG Breda, The Netherlands). 




































































Vesicle formation and morphology were assessed by cryogenic transmission electron microscopy 
(cryo-TEM). A thin aqueous film was formed by placing a drop of each sample on a glow-
discharged holey carbon grid and then blotting it with filter paper. The resulting thin films were 
vitrified by plunging the grid (kept at 100% humidity and room temperature) into ethane maintained 
at its melting point, using a Vitrobot (FEI Company, Eindhoven, The Netherlands). The vitreous 
films were transferred to a Tecnai F20 TEM (FEI Company) using a Gatan cryotransfer (Gatan, 
Pleasanton, CA), and the samples were observed in a low-dose mode. Images were acquired at 200 
kV at a temperature between -170/-175 °C by using low-dose imaging conditions not exceeding 20 
e−/Å2, with a CCD Eagle camera (FEI Company). 
The intensity-weighted mean diameter and polydispersity index (PI; a dimensionless measure of the 
broadness of the size distribution) were determined by Photon Correlation Spectroscopy using a 
Zetasizer nano-ZS (Malvern Instruments, Worcestershire, UK), which analyzes the fluctuations in 
intensity of the light backscattered by particles in dispersion. Zeta potential was estimated using the 
Zetasizer nano-ZS by means of the M3-PALS (Mixed Mode Measurement-Phase Analysis Light 
Scattering) technique, which measures the particle electrophoretic mobility. 
Curcumin content was quantified after disruption of the vesicles with methanol (1:1000), by using a 
HPLC chromatograph (Thermo Scientific, Madrid, Spain) equipped with a C18 Novapak column 
(Waters, Madrid, Spain). The mobile phase consisted of a mixture of acetonitrile/water/acetic acid 
(50:49:1), delivered at a flow rate of 1 ml/min, and detection was performed at 425 nm. The 
entrapment efficiency (EE%) was calculated and expressed as the percentage of curcumin post-
dialysis vs. pre-dialysis. 
Vesicle stability 
The vesicle dispersions were stored at 25 °C for 90 days, and their mean diameter, polydispersity 
index and zeta potential were measured at different time points. In parallel, the dispersions were 



































































freeze-dried, stored at 25 °C in air or under vacuum, and rehydrated at scheduled time periods to 
measure the mean diameter, polydispersity index and zeta potential.  
Vesicle behaviour at gastrointestinal pHs 
The vesicles (1 ml) were diluted with 9 ml of an acidic solution (pH 2) or a neutral solution (pH 7) 
containing sodium chloride (0.3 M), transferred into the basket of a dissolution rotating apparatus 
(US Pharmacopeia), thermostated at ~37°C and maintained for 2 h at pH 2, or for 6 h at pH 7. The 
mean diameter, polydispersity index and zeta potential of the vesicles were measured immediately 
after the dilution and at the end of the experiments. 
Small-Angle X-ray Scattering (SAXS) 
SAXS measurements were performed at the BL11-NCD (Non-Crystalline Diffraction) beamline at 
ALBA synchrotron facility (Cerdanyola del Vallès, Barcelona, Spain). The X-ray beam had a flux 
of 1012 photons/sec, with an energy of 10 keV and wavelength of 0.124 nm. The usable q range was 
0.09-4.77 nm−1. The samples were loaded in a flow through glass capillary mounted on an Anton 
Paar (Graz, Austria) KPR Peltier sample stage, which kept the temperature at 25 ºC. The ensemble 
was fixed to a motorized sample-stage, which allowed the sample to be aligned and oriented in the 
beam. Bidimensional X-ray scattering patterns were acquired using an ADSC Quantum 210r CCD 
detector. Exposure time per frame was 5 sec. The images were radially averaged and summed. Two 
series of diffraction patterns were obtained from the same capillary with a separation of 500 µm to 
check for reproducibility and possible radiation damage (which was not detected throughout the 
experiments). SAXS patterns were analyzed using a home-made fitting procedure based on a 
Gaussian description of the bilayers. Since symmetric bilayers did not give an accurate description 
of the spectra, the possibility of having different electronic density in the polar head region of one 
and the other side of the bilayer was introduced 12. The fitting model previously described by 
Caddeo et al. 12, was employed with a slight modification of the equation used to describe the polar 



































































heads represented by a symmetric Gaussian function, using ∆ρh1 and ∆ρh2 instead of an additional 
Gaussian (Eq. 1): 















































In vitro bioactivity of curcumin formulations against oxidative stress 
Caco-2 cells were grown as monolayer in 75 cm2 flasks, at 37 °C in humidified atmosphere of 5% 
CO2 in air. Dulbecco’s Modified Eagle Medium high glucose, containing L-glutamine, 
supplemented with 10% foetal bovine serum, 1% penicillin/streptomycin and 1% fungizone, was 
used as growth medium. Cells were seeded into 96-well plates at a density of 7.5×103 cells/well. 
After 24 h of incubation, cells were exposed to hydrogen peroxide (1:30000 dilution) for 4 h, in the 
presence or absence of curcumin in aqueous dispersion or loaded in vesicles (final concentration of 
curcumin 20 µg/ml). Cells treated with hydrogen peroxide-only were used as a positive control. 
After 4 h of incubation, the cells were washed with fresh medium, and their viability was 
determined by the MTT [3(4,5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide] colorimetric 
assay, by adding 100 µl of MTT reagent (0.5 mg/ml in PBS) to each well. After 3 h, the formed 
formazan crystals were dissolved in dimethyl sulfoxide, and the concentration was 
spectrophotometrically quantified at 570 nm with a microplate reader (Synergy 4, Reader BioTek 
Instruments, AHSI S.p.A, Bernareggio, Italy). The results are reported as the percentage of 
untreated cells (100% viability). 
In vitro curcumin stability and release 
The stability of curcumin loaded in vesicles was assessed by monitoring the chromatographic 
profile and the concentration of the polyphenol over 8 h of incubation in cell medium under 
constant stirring at 37 °C, by HPLC (see Vesicle characterization section). 
The release of curcumin from the vesicles was measured by diluting the formulations (2 ml) with 
cell medium (2 ml), and keeping the dispersions under stirring for 8 h at 37 °C. At regular time 
intervals (2, 4, 6 and 8 h), samples were centrifuged at 10000 rpm for 5 min at 0 °C. After 



































































centrifugation, the formation of three strata was observed: the superior one was yellow transparent 
and contained the smaller vesicles, the intermediate one was gel-like and yellowish and contained 
the larger vesicles, and the inferior one was intensely coloured in yellow/orange and contained free 
curcumin. The two vesicle strata were recovered and the initial volume (4 ml) was restored with 
fresh medium to continue the release study, while the pellet was solubilized in methanol to quantify 
curcumin by HPLC. 
In vitro cell uptake of vesicles 
Caco-2 cells were grown as monolayer in poly-L-Lysine coated 8-well  µ-slide (Ibidi GmbH, 
Martinsried, Germany) and incubated with the vesicles labelled with 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl (Rho-PE; Avanti Polar Lipids, Alabama), 
and 5(6)-carboxyfluorescein (CF, Sigma-Aldrich, Milan, Italy). The uptake of the vesicles was 
investigated in living cells, at 1, 2 and 4 h, by confocal laser scanning microscopy (CLSM) using a 
FluoView FV1000 confocal microscope (Olympus, Barcelona, Spain). Pictures were taken in z-
stacks using a 60× objective. 
In vivo studies 
In vivo studies adhered to the principles of laboratory animal care and use, and were performed in 
accordance with the European Union regulations for the handling and use of laboratory animals and 
the protocols were approved by the Institutional Animal Care and Use Committee of the University 
of Valencia (code 2016/VSC/PEA/00159 type 2). Male Wistar rats, aged 8-12 weeks and weighing 
230-250 g, were housed in air-conditioned rooms at 22±3°C, 55±5% humidity, 12 h light/dark 
cycles, with free access to water and chow. 
Intestinal biodistribution of hydrophilic macromolecules 
Phycocyanin, a macromolecular, hydrophilic, fluorescent marker, was used to label the vesicles and 
possibly predict the distribution of Nutriose®. The labelled vesicles or the phycocyanin solution (2 
ml) were intragastrically administered to healthy rats by gavage (n=4 per group). At 3, 5 and 7 h, 



































































rats were sacrificed, the intestines removed, slightly stretched and carefully spread on a dissecting 
board, and observed by using the In-Vivo FX PRO Imaging System (Bruker BioSpin, USA). 
Phycocyanin  biodistribution was observed (excitation at 640 nm and emission at 680 nm), while 
curcumin fluorescence overlapped with the spectrum of the intestinal lumen content. 
Intestinal biodistribution of curcumin 
Curcumin dispersion or curcumin loaded vesicles (2 ml) were intragastrically administered to 
healthy rats by gavage (n=4 per group). After 3 h, the rats were sacrificed, and liver, kidneys and 
intestines were excised. The intestines were emptied and divided in segments: duodenum, jejunum, 
cecum and colon, slightly stretched and carefully spread on a dissecting board. Liver, kidneys, and 
intestine specimens were soaked in acetonitrile:water (70:30), homogenized and centrifuged at 
12500 rpm for 10 min. The amount of curcumin was quantified by HPLC (see Vesicle 
characterization section). Results were expressed as the ratio of the amount of curcumin in the 
harvested organ vs. the amount of curcumin administered. 
Pharmacokinetics of curcumin 
Twenty-four hours before curcumin administration, animals were subjected to jugular vein 
cannulation, and after surgery, they were allowed to recover from the anesthesia. 3 ml of curcumin 
dispersion (10 and 20 mg/ml) or curcumin loaded vesicles (10 mg/ml) were intragastrically 
administered to healthy rats by gavage (n=5 per group). After administration, blood samples (0.2 
ml) were withdrawn into heparinized syringes at scheduled time points, up to 8 h. Each blood 
sample was deproteinized with acetonitrile and centrifuged at 3000 rpm for 5 min, and the plasma 
was stored at -20ºC until assayed for curcumin content by HPLC. The chromatographic analyses 
were performed in a Perkin Elmer® HPLC Series 200 equipped with a binary pump, an auto-sample 
and a fluorescence detector. Identification and quantification of curcumin were performed in a 
Teknokroma® Brisa “LC2” C18 column (5.0 µm, 150 × 4.6 mm). Curcumin was eluted isocratically 
at a flow rate of 1 ml/min using 20 mM acetate buffer pH 3.0 and methanol (40:60, v/v) as a mobile 



































































phase, and 50 µl for the injection volume. Excitation and emission wavelengths of elute 
fluorescence were optimized for measurement at 420 and 530 nm, respectively. 
The pharmacokinetic parameters were calculate using a non-compartmental analysis by Phoenix 
WinNonlin®. The maximum observed plasma concentration (Cmax) and the time taken to reach it 
(tmax) were obtained from the curve plotting curcumin concentration vs. time. The area under each 
drug concentration time curve (AUC, ng/ml h) to the last data point was calculated by the linear 
trapezoidal rule and extrapolated to time infinity by the addition of CLast/Ke, where CLast is the 
concentration of the last measured plasma sample. 
Efficacy of curcumin against colitis 
Chronic inflammation in rat colon was chemically induced as previously described 6,13, with slight 
modifications. Rats (n=4 per group) were anesthetized with isoflurane, and TNBS (0.13 M) 
dissolved in ethanol/water (50:50) was instilled (0.5 ml) into the colon lumen (day 0). Healthy 
animals were the negative control; animals with TNBS-induced colitis treated with saline were the 
positive control; the other groups consisted of animals with colitis receiving curcumin dispersion or 
curcumin liposomes, nutriosomes or HPMC-nutriosomes (2 ml) by oral gavage daily for 3 days, 
when inflammation was most intense (days 3, 4 and 5 after TNBS rectal administration). 
On day 9, the rats were euthanized with an overdose of sodium pentobarbital (Dolethal®, 
Vetoquinol, UK), the abdomen was cut open, and the distal colon was removed. The extent and 
severity of colitis was evaluated by visual inspection of the excised colon, along with the 
measurement of myeloperoxidase activity (MPO). MPO was used as an index of inflammation and 
was measured according to an established method 6,13. Briefly, each colon specimen was soaked in 
750 µl of hexadecyltrimethylammonium bromide buffer (0.5% in 80 mM phosphate buffer pH 5.4) 
and homogenized. The homogenate was centrifuged (Heraeus Fresco 17 Centrifuge, Thermo 
Electron Corporation, Spain) at -1°C and 1000 rpm for 15 min. The supernatant was incubated with 



































































hydrogen peroxide and tetramethylbenzidine. The reaction was stopped with 2 N H2SO4, and the 
absorbance was measured spectrophotometrically at 450 nm. 
Statistical analysis of data 
Results are expressed as the mean±standard deviation. Analysis of variance (ANOVA test) was 
performed to assess the differences among groups using the IBM SPSS statistics 20.0 for Windows. 
Post hoc testing (p=0.05) of multiple comparisons was performed by the Scheffe or Dunnet tests. 
3. RESULTS 
Vesicle characterization 
Nutriosomes, HPMC-nutriosomes and liposomes were easily fabricated in a one-step procedure, 
without the use of organic solvents or energetic and dissipative procedures, by keeping the 
phospholipid and the other components in water, and by sonicating the dispersion to form lamellar 
vesicles and adjust their size and lamellarity. The sample composition is reported in Table 1. 
 










Liposomes 160 10 0 0 
Nutriosomes 160 10 50 0 
HPMC-nutriosomes 160 10 50 1 
 
The actual formation of the vesicles and their morphology were confirmed by cryo-TEM 
observation. The images of liposomes displayed spherical and mostly unilamellar vesicles, with a 
few multilamellar vesicles (Figure 1A). Nutriosomes were spherical in shape, and both 
multilamellar, multicompartment structures and unilamellar vesicles were observed (Figure 1B). 
HPMC-nutriosomes were basically spherical and unilamellar (Figure 1C). 
 




































































Figure 1. Representative cryo-TEM images of curcumin loaded liposomes (A), nutriosomes (B) 
and HPMC-nutriosomes (C). 
 
The mean diameter of empty liposomes was ~107 nm, and the addition of curcumin led to a 
significant increase in size up to ~181 nm (p<0.01) and zeta potential from -12 to -37 mV (p<0.01), 
which indicate a localization of curcumin not only within the bilayer, but also onto the bilayer 
surface (Table 2) 14,15. 
 
Table 2. Mean diameter (MD), polydispersity index (PI), zeta potential (ZP) and entrapment 
efficiency (EE) of empty and curcumin loaded liposomes, nutriosomes and HPMC-nutriosomes. 











Empty liposomes 107±8 0.35 -12±4  
Empty nutriosomes 127±7 0.24 -13±3  
Empty HPMC-nutriosomes 135±6 0.31 -14±6  
Curcumin liposomes  181±7 0.33 -37±4 #73±6 
Curcumin nutriosomes 183±8 0.35 -39±2 *88±7 
Curcumin HPMC-nutriosomes 153±8 0.34 -36±7 *91±6 
 



































































The addition of Nutriose® led to a small increase of the mean diameter of empty nutriosomes in 
comparison with empty liposomes (from ~107 to ~127 nm, p<0.05), while in curcumin loaded 
nutriosomes the effect of the dextrin was mitigated by the presence of the polyphenol, as liposomes 
and nutriosomes showed the same mean diameter and zeta potential (~182 nm and ~-38 mV, 
p>0.05 between the two samples). The further addition of HPMC led to a slight increase in size for 
empty nutriosomes, while a decrease was observed upon incorporation of curcumin (~153 nm, 
p<0.05 vs. liposomes and nutriosomes). 
The stability of the vesicle dispersions was evaluated during storage at 25°C. After 60 days, the 
mean diameter of all the samples significantly increased (data not shown). As an alternative, the 
dispersions were freeze-dried and kept at 25°C in air or under vacuum. The samples were 
rehydrated every 30 days up to 180 days, and the size, polydispersity index and zeta potential were 
measured (Figure 2).  
 



































































Figure 2. Mean diameter, polydispersity index (PI) and zeta potential of curcumin loaded 
liposomes, nutriosomes and HPMC-nutriosomes lyophilized, kept under vacuum for 180 days, and 
rehydrated at different time periods. Bars represent standard deviations (n=3). 
 
The size of liposomes remained almost constant during the first 60 days, then the mean diameter 
and polydipersity index increased up to ~450 nm and 0.6, respectively. On the contrary, the 
parameters of both nutriosomes and HPMC-nutriosomes remained constant over the whole storage 
period, indicating a positive effect of Nutriose® on the vesicle re-formation, probably because the 
soluble dextrin acted as a cryo-protector avoiding structural collapse of the vesicles during the 
dehydration process. 
The resistance of the vesicles to pH variations and ionic strength was evaluated by incubating the 
formulations with appropriate solutions (pH 2 or 7 and 0.3 M NaCl), and monitoring the vesicle 
size, polydispersity index and zeta potential (Table 3) 6. 
 
Table 3. Mean diameter (MD), polydispersity index (PI), zeta potential (ZP) and entrapment 
efficiency (EE) of liposomes, nutriosomes and HPMC-nutriosomes diluted and incubated with 
acidic solution (pH 2) for 2 h or with neutral solution (pH 7) for 6 h, both containing sodium 
chloride (0.3 M), at 37°C. The measurements were carried out immediately after the dilution (t0h) 














t0h 205±40 0.41 13±3  
t2h 557±20 0.58 11±2 79±6 
Nutriosomes 2 
t0h 174±15 0.37 13±4  
t2h 394±49 0.50 8±5 93±10 
HPMC-nutriosomes 2 
t0h 199±19 0.40 10±4  
t2h 224±42 0.49 9±5 89±9 
Liposomes 7 
t0h 181±20 0.42 0±2  
t6h 162±5 0.39 -1±2 33±12 




































































t0h 170±7 0.47 0±2  
t6h 166±49 0.41 -4±3 49±5 
HPMC-nutriosomes 7 
t0h 134±21 0.48 -2±5  
t6h 204±8 0.49 -1±2 56±7 
 
After 2 h at pH 2, the size of liposomes increased up to 557 nm and the polydispersity index up to 
0.58, which indicats a partial loss of their structure. On the contrary, the size of nutriosomes was 
less affected by the acidic pH (394 nm), and even less in the case of HPMC-nutriosomes (224 nm). 
Under these conditions, the zeta potential of the samples turned to positive values. After 6 h at pH 
7, both liposomes and nutriosomes did not undergo marked alterations, while HPMC-nutriosomes 
increased in size, presumably due to swelling, which follows polymer hydration leading to 
relaxation of polymer chains and their entanglement to form a viscous gel layer around the vesicles. 
SAXS analysis 
Empty liposomes showed the typical spectra of multilamellar vesicles (Figure 3A), with a large 
number of unilamellar (i.e., uncorrelated) structures (20% correlation; Table 4), while curcumin 
loaded liposomes (phospholipid:curcumin molar ratio 8.6:1) were predominantly unilamellar, with a 
small population (6%; Table 4) of multilamellar (i.e., correlated) vesicles (Figure 3A). 
The multilamellar liposomes, from both spectra, showed similar repetition distance (d, 6.21 and 
6.28 nm for empty and curcumin loaded liposomes, respectively; Table 4). Because of the high 
preponderance of unilamellar vesicles, the parameters associated with the structure (Caillé 
parameter η, and number of correlated and uncorrelated lamellae N and Nunc) have high uncertainty. 
The main differences in the bilayer structure of empty and curcumin loaded liposomes refer to the 
width of the head group and methylene gaussians (σh and σc, respectively; Table 4), which are 
smaller for curcumin loaded liposomes, as can also be observed in the electron density plots 
showing more pronounced polar head and methylene gaussians (Figure 3B). This is in contrast with 
the observations of Hung et al. 16 that observed an increase of both σh and σC when curcumin was 
added to dioleoylglycerophosphocholine liposomes. Moreover, Hung et al. detected a reduction in 



































































the phosphate peak-to-phosphate peak distance (equivalent to 2 Zh) of about 0.1 nm for 
curcumin/lipid molar ratios above 0.02, while we observed a reduction of 0.03 nm at the present 
curcumin/lipid molar ratio of 0.13. However, it has to be noted that Hung et al.’s experiments were 
conducted below complete hydration. 
 
Figure 3. Experimental SAXS intensity (symbols) and fitted model (lines) are shown in the left 
panel, electron density profiles in the right panel for empty and curcumin loaded liposomes (A-B), 
nutriosomes (C-D), and HPMC-nutriosomes (E-F). 
 



































































The electron density of the polar head (∆ρh; Table 4) increased when curcumin was loaded, which 
might be a consequence of curcumin replacing some of the water molecules that hydrate the polar 
heads. 
The scattering profiles of empty and curcumin loaded nutriosomes were the result of the subtraction 
of Nutriose® (50 mg/ml) spectrum (Figure 3C). The profile of empty nutriosomes showed the 
typical peaks of multilamellar vesicles (corresponding to 42% of the sample; Table 4). Nutriose® 
seems to interact weakly with the bilayer, as demonstrated by the similar spectra of empty 
liposomes and nutriosomes. This can be explained by the fact that water-soluble Nutriose® is 
supposedly localized in the aqueous compartments of the vesicles (internal core, interlamellar 
space, and intervesicle medium). However, the dextrin seems to affect the arrangement of the 
vesicles, as it increased the lamellarity (from 20 to 42% of multilamellar structures; Table 4) and 
rigidity observed as a significant reduction of Caillé parameter (η; Table 4) when comparing the 
results of nutriosomes and liposomes. These effects can be due to the ability of Nutriose® to reduce 
the interlamellar repulsion due to its solubilization in the aqueous layers where solvent dielectric 
constant is decreased as a result of the increased number of ionized groups on the interfacial bilayer 
regions 17,18.  
 
Table 4. Fitting derived parameters obtained from SAXS analyses at 25 °C of empty and curcumin 





















d (nm) 6.21±0.05 5.97±0.05 5.97±0.05 6.28±0.05 6.10±0.05 5.98±0.05 
η 0.10±0.04 0.06±0.01 0.07±0.01 0.12±0.05 0.04±0.04 0.05±0.01 
N 5.9±2 7.9±1 8.0±1 54±2 3.9±1 15±4 
σh (nm) 0.39±0.05 0.39±0.05 0.35±0.05 0.33±0.05 0.42±0.02 0.15±0.05 
∆ρh1 (e/nm
3) 83±5 97±5 102±5 115±5 52±5 89±5 




































































3) 103±5 129±5 146±5 129±5 53±5 168±5 
Zh (nm) 1.67±0.05 1.70±0.05 1.69±0.05 1.66±0.05 1.63±0.05 1.60±0.05 
σc (nm) 0.35±0.10 0.22±0.10 0.17±0.10 0.29±0.10 0.07±0.10 0.05±0.10 
Nunc 24±5 11±5 10±5 800±100 5.9±2 650±1000 
% correlation 20 42 43 6 29 2 
 
d, repetition distance; η, Caillé parameter; N, number of correlated lamellae; σh, polar head 
Gaussian width with electron density difference to the media, ∆ρh1 and ∆ρh2, for each bilayer leaflet; 
Zh, position of the polar head Gaussian with respect to the bilayer center; σc, methylene groups 
Gaussian width at the center of the bilayer; Nunc, number of uncorrelated lamellae. 
 
A reduction of the lamellar spacing was also observed (d, from 6.21 to 5.97 nm; Table 4), which 
may be caused by an increase in rigidity of the bilayers. On the other hand, the presence of 
curcumin reduced the intensity of the peaks, and the bands corresponding to unilamellar vesicle 
predominate. When comparing the electron density profiles of empty and curcumin loaded 
nutriosomes, the main finding is the thinning of the bilayer (i.e., decrease in thickness) when 
curcumin was loaded, due to the dehydration of the polar heads (Figure 3D; σH, Table 4). At the 
same time, the hydrophobic part (Figure 3C; σC, Table 4) of the phospholipid became more ordered, 
and the dip due to the methylene groups became more distinct, which is probably a consequence of 
the partial dehydration of the polar heads. 
In Figure 3E, the spectra of empty and curcumin loaded HPMC-nutriosomes are reported. As can be 
deduced by comparing the spectra of HPMC-nutriosomes and nutriosomes, the effect of HPMC on 
the bilayer structure and ordering is minimal. Again, curcumin reduced notably the number of 
multilamellar vesicles (from 43 to 2%; Table 4), as only a small signal corresponding to 
multilamellar structures was still visible. The effect of curcumin was very similar to that observed 
in curcumin loaded liposomes, which showed a spectrum typical of an entirely unilamellar vesicle 
system, with a small population (6% and 2% for curcumin liposomes and HPMC-nutriosomes, 
respectively; Table 4) of significantly multilayered vesicles. This effect can be deduced from the 



































































comparison of the number of correlated bilayers and uncorrelated bilayers (N and Nunc, 
respectively; Table 4). 
While the asymmetry of the bilayer (as quantified by the difference between ∆ρh1 and ∆ρh2) is only 
marginally affected by the presence of Nutriose®, it seems clear that the presence of HPMC has a 
strong effect, increasing the electron density difference (Figure 3F). We should remark that a 
similar effect on the fitting could be obtained by letting the headgroup position to differ, instead of 
the electron density, because both have a strong cross-correlation and the fits of the HPMC were not 
optimal. 
Summarizing, we can say that the effect of curcumin is dramatic on the SAXS profiles of all the 
vesicle systems studied, which is not on the bilayer thickness and electron density distribution, but 
on the lamellarity. At present, the reason behind the strong increase in the presence of uncorrelated 
lamellae (i.e., unilamellar structures) is not clear. The overall effect of curcumin on the bilayer is an 
increase in rigidity (decrease of Caillé parameter η) and a reduction of the width of the polar heads 
(σh). On the other hand, the presence of Nutriose
® and HPMC increase the dissymmetry of the 
bilayer, which suggests that they partition preferably to one of the leaflet. Since the model does not 
distinguish between the inner and the outer leaflet, we cannot say whether Nutriose® and HPMC are 
localized/adsorbed in the concave or convex leaflet. 
In vitro bioactivity of curcumin formulations against oxidative stress 
The ability of curcumin loaded vesicles to neutralize free radicals and protect Caco-2 cells from 
oxidative stress caused by hydrogen peroxide was demonstrated, as compared to the effect of 
curcumin dispersion at the same concentration (Figure 4). 
 




































































Figure 4. Viability of Caco-2 cells exposed to hydrogen peroxide alone or simultaneously treated 
with curcumin aqueous dispersion or curcumin loaded liposomes, nutriosomes and HPMC-
nutriosomes. Data are reported as mean values ± standard deviation (error bars) of cell viability 
expressed as the percentage of the negative control (100% viability). *,° different symbols indicate 
statistically different values (p<0.05). 
After hydrogen peroxide exposure, cell viability was halved (~50%). It increased slightly when the 
curcumin dispersion was applied (~70%, p>0.05), to a greater extent when using curcumin loaded 
liposomes and nutriosomes (~110%, p<0.05 between liposomes and nutriosomes, and p<0.01 vs. 
hydrogen peroxide-exposed cells), and even more when using HPMC-nutriosomes (~137%, p<0.01 
vs. all the samples). The results highlighted the important role played by the phospholipid vesicles 
in enhancing the activity of curcumin, and a further improvement provided by HPMC. 
In vitro curcumin stability and release  
The chromatographic profiles of curcumin did not show significant variations after incubation in 
cell medium for 8 h, and the concentration of curcumin did not decrease. This demonstrates that no 
degradation occurred, thus proving the stability of the polyphenol under the experimental conditions 
tested (Figure 5 A and B) 19. 



































































The amount of curcumin released from liposomes reached a maximum at 2 h (~80%), and remained 
constant up to 8 h. On the contrary, the release of curcumin from nutriosomes and HPMC-




Figure 5. Representative chromatograms of curcumin before (A) and after 8 h of incubation (B) of 
curcumin liposomes, nutriosomes and HPMC-nutriosomes in cell medium. 
Release profiles of curcumin from liposomes, nutriosomes and HPMC-nutriosomes (C) over 8 h in 
cell medium. 
 
In vitro cell uptake  
The uptake of liposomes, nutriosomes and HPMC-nutriosomes by Caco-2 cells was evaluated after 
1, 2 and 4 h of incubation with the vesicles labelled with Rho-PE, as a lipid marker (red 
fluorescence), and CF, as a hydrophilic marker (green fluorescence) (Figure 6). The images of cells 
incubated with liposomes, at 1, 2 and 4 h disclosed a non-time dependent accumulation of Rho-PE 
in the perinuclear area, while no localisation of CF within the cells was observed, as it was confined 
to the external medium. This may indicate that a rupture of liposomes occurred during the 
internalization process. The images of the cells treated with labelled nutriosomes showed a different 



































































behaviour: Rho-PE was localized in the perinuclear area, CF was mainly accumulated in the 
cytoplasm, and a yellow fluorescence was also observed in the peripheral area of the cytoplasm, 
which indicates the co-localization of the two probes presumably internalized in intact vesicles. The 
cells incubated with HPMC-nutriosomes showed an even more evident co-localization of the 
probes. The yellow fluorescence was similar to that observed for nutriosomes after 1 h of 
incubation, while it was more intense at 2 and 4 h, which indicates a massive internalization of 
vesicles and aggregation in the peripheral area of the cytoplasm. The increased uptake of HPMC-
nutriosomes is probably related to the presence of the polymer, which may favour the interaction 
between cells and vesicles. 
 
 
Figure 6. CLSM images of Caco-2 cells exposed to liposomes, nutriosomes and HPMC-
nutriosomes labelled with Rho-PE (red) and CF (green) for 1, 2 and 4 h. The bar corresponds to 50 
µm.  
 
In vivo biodistribution of hydrophilic macromolecules in the gastrointestinal tract 



































































To evaluate the gastrointestinal transit of the formulations and to establish their ability to facilitate 
dextrin and curcumin delivery in vivo, the vesicles were labelled with phycocyanin, which is a 
water-soluble, fluorescent macromolecule 20. The labelled vesicles loading curcumin were 
administered to healthy rats, and their biodistribution in the gastrointestinal tract was monitored as a 
function of time by using the In Vivo FX PRO Imaging System, which allowed the precise 
localization of the markers. An aqueous dispersion of phycocyanin and curcumin was also 
administered and used as a reference. The fluorescence of phycocyanin was visualized in blue, 
while the fluorescence of curcumin overlapped with the spectrum of the intestinal lumen content 
(Figure 7). When the phycocyanin solution was administered, the fluorescence decreased over time: 
after 3-5 h, the fluorescence was moderate and restricted to the final part of the intestine, mostly 
jejunum and slightly in the cecum and colon, while it disappeared after 7 h. Liposomes provided a 
more widespread and persistent fluorescence in comparison with the solution: after 3-5 h, the signal 
was more evident in duodenum and jejunum, and after 7 h, a weak signal was visible also in cecum 
and colon.  




































































Figure 7. Fluorescence images of the gastrointestinal tract excised from healthy rats treated with a 
dispersion of phycocyanin and curcumin or phycocyanin-labelled curcumin-loaded liposomes, 
nutriosomes and HPMC-nutriosomes. 
 
After nutriosome administration, the most intense fluorescence was observed: after 3 h, it was 
diffused in the stomach, duodenum and upper part of jejunum; after 5 h, it shifted in the whole 
jejunum and slightly in the cecum; after 7 h, it was detected in the final part of jejunum and slightly 



































































in cecum and colon. After HPMC-nutriosome administration, the florescence distribution was 
similar to that observed for nutriosomes, but less intense and extensive. Hence, all the vesicles 
enhanced the fluorescence biodistribution and intensity with respect to that provided by the 
solution, and especially nutriosomes were able to prolong and extend the distribution of the 
macromolecule in the whole intestine, even in the colon. 
In vivo biodistribution of curcumin in the intestines 
The biodistribution of curcumin in the different parts of the intestine, 3 h after administration, was 
assessed by HPLC quantification (Figure 8). 
 
 
Figure 8. Amount (%) of curcumin found in the different segments of the gastrointestinal tract, 3 h 
after its administration in aqueous dispersion or in liposomes, nutriosomes and HPMC-nutriosomes. 
Data are reported as mean values ± standard deviation (error bars). 
 
The dispersion provided a higher accumulation of curcumin in the duodenum (~5%) and jejunum 
(~16%), and much lower in cecum and colon (~1%). Liposomes allowed a high accumulation in the 
jejunum (~7%) and cecum (~3%), and less in the other segments (<1%). The accumulation obtained 



































































after administration of nutriosomes and HPMC-nutriosomes was similar in the duodenum and 
jejunum (~20%), while it was higher in the cecum (~12%) and colon (~3% ). In agreement with the 
biodistribution of the hydrophilic marker, this study confirmed the superior ability of nutriosomes 
and HPMC-nutriosomes to facilitate the local accumulation of curcumin in the intestines. In vivo 
biodistribution results showed that the amount of curcumin found in liver and kidneys was 
negligible (data not shown). 
Pharmacokinetics of curcumin 
The pharmacokinetic studies showed the effect of the nanoincorporation on curcumin plasma 
concentration. Curcumin levels in blood were determined at 10 different time points up to 8 h after 
a single dose of dispersion or vesicle formulations administered in rats orally (Figure 9). 
 
 
Figure 9. Curcumin plasma concentration over 8 h after a single-dose administration of an aqueous 
dispersion or liposomes, nutriosomes and HPMC-nutriosomes. Data are reported as mean values ± 
standard deviation (error bars). 
 



































































The plasma concentration of curcumin was not detectable when administering 30 mg of the 
polyphenol in aqueous dispersion, and a double amount (60 mg) was necessary to allow 
quantification. The plots of plasma concentration vs. time displayed a flat and low pharmacokinetic 
profile for the dispersion, as compared to fluctuating and higher profiles observed for all the vesicle 
formulations. Cmax/D and AUC/D were more than 10-, 7.25- and 10.44-fold higher when liposomes, 
nutriosomes or HPMC-nutriosomes were used, in comparison with the curcumin dispersion. Tmax 
results should be interpreted with caution, since the measurement of the curcumin plasma 
concentration, when the dispersion was administered, did not show a Cmax as clear and high as that 
observed when using the vesicle formulations (Figure 9). This demonstrates the carrier capabilities 
of nutriosomes, which facilitated not only the curcumin local accumulation in the whole intestine, 
but also the passage of the polyphenol through the intestinal mucosa towards the systemic 
circulation, providing a maximum concentration 12-15-fold higher (Cmax/D), and an overall 
exposure up to 10-fold higher (AUClast/D) than that of the dispersion using half of the dose. 
In vivo efficacy of curcumin against colitis 
Colitis was induced in rats by intracolonic application of TNBS, and the therapeutic efficacy of 
curcumin was assessed as a function of the incorporation in the investigated nutriosomes and 
liposomes. The tissue damage was macroscopically evaluated by visual inspection of the internal 
and external walls of the colon (Figure 10). The colon of healthy rats was intact and pink-coloured, 
with a constant width for the entire length. The colon from TNBS rats treated with saline (positive 
control) showed thickening, ulcerated mucosal lesions, and oedematous inflammation, which 
caused strong dilatation. Similar features were observed when the curcumin aqueous dispersion was 
administered. On the contrary, the colon of the TNBS rats treated with the vesicle formulations 
were very similar to those of healthy controls, in diameter and colour, especially those treated with 
nutriosomes, while a reduction in length and small necrotic areas were observed in the animals 
treated with liposomes and HPMC-nutriosomes. 



































































The colonic damage induced by TNBS was associated with an increase in MPO activity in 
comparison with healthy controls, indicative of neutrophil infiltration in the inflamed tissue. 
 
 
Figure 10. Macroscopic appearance of colon tissue from healthy or colitic rats treated with a 
curcumin aqueous dispersion or liposomes, nutriosomes and HPMC-nutriosomes. MPO values are 
reported in ng/ml. 
 
The MPO activity increased significantly in TNBS rats (from 4 to 52 ng/ml; Figure 10), and it was 
slightly mitigated by the curcumin dispersion. On the other hand, the administration of curcumin 
loaded vesicles resulted in a marked reduction of MPO activity, especially using nutriosomes and 
HPMC-nutriosomes (~12 ng/ml; Figure 10), even if the values were not statistically different 
(p>0.05) from that found for liposome-treated animals. The results indicate that liposomes 
potentiate the ability of curcumin to inhibit MPO, which could not be further extended by 
nutriosomes and HPMC-nutriosomes, despite the higher bioavailability of the polyphenol they 
provide. 
 




































































Environmental pollution, modern food and beverages contain additives that can cause oxidative 
stress in human intestine. The cellular antioxidants are not able to neutralize the overproduced 
reactive oxygen species (ROS), which results in chronic bowel inflammation and systemic 
oxidative stress, frequently correlated with carcinogenesis 21. 
The findings of the present work confirm that the combination of phospholipid, prebiotic dextrin 
and antioxidant curcumin in a novel phospholipid vesicle formulation, namely nutriosomes, 
represents a promising approach to prevent and counteract the above physio-pathological 
conditions. Moreover, nutriosomes were prepared without the use of organic solvents, by means of 
a one-step, easy and scalable procedure. 
Cryo-TEM and SAXS studies displayed that nutriosomes assembled in unilamellar and 
multilamellar, multicompartment vesicles, stabilized by the presence of Nutriose® in the inter-
lamellar and inter-vesicle medium. The presence of curcumin reduced notably the number of 
multilamellar vesicles. Additionally, HPMC reduced the vesicle lamellarity producing almost 
unilamellar-only structures, probably due to the polymer adsorption onto the bilayer surface. The 
soluble dextrin played an important role as a cryo-protector, avoiding vesicle collapse during the 
lyophilization process: both nutriosomes and HPMC-nutriosomes, when freeze-dried and stored 
under vacuum up to 180 days, could be easily re-formed by rehydration, basically preserving their 
size and structure. The high phospholipid concentration (160 mg/ml) used to prepare the vesicles 
ensured an acceptable resistance of liposomes to high ionic strength and pH changes encountered in 
the gastrointestinal environment. The additional presence of Nutriose® improved the resistance of 
nutriosomes, and HPMC further protected the vesicles, presumably thanks to the formation of a 
polymer layer around the surface of the vesicles. It seems reasonable to presume that the 
incorporation of curcumin in the vesicles prevented direct contact of the polyphenol with the gastro-
intestinal media and its degradation. 



































































When the formulations reach the intestines, intact vesicles could enhance the ability of curcumin to 
neutralize reactive oxygen species associated to oxidative injury in cells 22–24. The protective effect 
against hydrogen peroxide-induced oxidative stress in Caco-2 cells, which were used as intestinal 
cell model because they grow as monolayer and express several morphological and biochemical 
characteristic of the small intestine enterocytes 25, was evaluated using curcumin in aqueous 
dispersion or loaded in vesicles. The highest survival of stressed cells was obtained when 
nutriosomes and mostly HPMC-nutriosomes were used, while the curcumin dispersion was not able 
to counteract the oxidative effect of hydrogen peroxide. The results confirmed the great ability of 
nutriosomes to interact with cells and promote the local antioxidant effect of the polyphenol. Its 
efficacy was further improved by HPMC-nutriosomes, possibly due to the more extensive cell 
internalisation (Figure 6). Moreover, other factors could contribute to potentiate the curcumin 
efficacy using HPMC-nutriosomes, such as increased stability, bioavailability, and release rate, 
which was slower as compared to liposomes (Figure 5). 
Nutriosomes exhibited large affinity and distribution towards the epithelial mucosal surface of the 
intestine, improving to a large extent the local accumulation of both curcumin and water-soluble, 
macromolecular phycocyanin, used to simulate the fate of Nutriose®, with respect to a dispersion of 
the polyphenol and phycocyanin, and liposomes. 
Previous pharmacokinetic studies on curcumin reported a low intestinal absorption after oral 
administration, resulting in poor systemic bioavailability and rapid clearance from the body 26–29. To 
overcome these problems, several curcumin nanoformulations have been developed and tested 30,31. 
Maiti et al. reported the formation of a curcumin complex with phospholipids capable of enhancing 
its therapeutic efficacy, which was related to better absorption and bioavailability of the molecule 
32. In this work, curcumin incorporated in liposomes, nutriosomes, and HPMC-nutriosomes showed 
higher systemic bioavailability (7.44-10.44 fold) in plasma than that provided by the dispersion 
upon oral administration. Additionally, the vesicles promoted the distribution of curcumin in the 
intestinal membrane to a greater extent than the free polyphenol in dispersion. Hence, the vesicles 



































































could modify the pharmacokinetics and biodistribution of the incorporated curcumin. A similar 
enhanced effect was previously found by other authors, and might be attributed to an improved 
diffusion of particles through the mucus, and a higher interaction with the epithelial walls due to the 
adhesive properties of nanocarriers 32–34. 
In addition, the degree of inflammation and tissue injury caused by TNBS was substantially reduced 
in rats treated with the vesicle formulations, as demonstrated by the reduction of inflammation 
biomarkers in comparison with the curcumin dispersion. 
5. CONCLUSIONS 
In the present study, nutriosomes were successfully developed by combining phospholipids at high 
concentration, a prebiotic dextrin, an antioxidant polyphenol, and possibly a polymer, by using a 
simple, organic solvent-free, reproducible method. Nutriosomes were proposed as an oral 
formulation for the protection of intestine, thanks to the combined activity of Nutriose® and 
curcumin. Physico-chemical investigations demonstrated that the association of the dextrin and the 
polyphenol in phospholipid vesicles was crucial for vesicle features and stability. Moreover, the 
results obtained in vivo supported the hypothesis that nutriosomes enhanced the accumulation of 
both the dextrin and curcumin in the different segments of the intestine. The systemic 
bioavailability of curcumin was also increased after oral administration of the vesicle formulations. 
Additionally, chemically-induced colonic damage was reduced by the vesicles, in particular by 
nutriosomes thanks to the association of the prebiotic dextrin and the antioxidant curcumin. 
Overall results suggest that curcumin nutriosomes represent a promising tool for the intestinal 
treatment of oxidative stress injuries, and they can be proposed for the development of functional 
foods, dietary supplements, and pharmaceutical preparations thanks to their easy preparation 
method, biocompatibility and promising performances in vivo. 
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